Browse & search snapshots

Notices and Early Consultation - Legislation and Guidelines - Drugs and Health Products - Health Canada The following regulatory notices and/or proposals are currently under early consultation prior to pre-publication in the Canada Gazette Part I. There are currently no…

Interim Orders "The Minister may make an interim order that contains any provision that may be contained in a regulation made under this Act if the Minister believes that immediate action is required to deal with a significant risk, direct or indirect, to health, safety or the…

Glossary Active substance The medicinal ingredient in a drug that is responsible for the therapeutic actions of the drug. Adults In the context of clinical trials, usually defined as individuals 18 years of age and older. Adolescent Usually defined as individuals 12 years old and…

Each method is explained directly below and an example is provided.

Health Canada's Clinical Trials Database Frequently Asked Questions What is Health Canada's Clinical Trials Database? Health Canada's Clinical Trials Database is a listing of information about phase I, II and III clinical trials in patients. The database is managed by Health…

Base de données sur les essais cliniques de Santé Canada Santé Canada, grâce à sa base de données sur les essais cliniques, donne à la population une liste de renseignements précis sur les essais cliniques des phases I, II et III chez les patients. Gérée par Santé Canada, la base…

How to Pay Health Canada Fees On this page Requirements Payment Options Existing Credit on Account Online Banking through Canadian Financial Institution (via Bill Payment Service -BPS) Direct Deposit Wire Transfer/Electronic Funds Transfers (EFT) Cheque, Money Order or Bank Draft…

Information Sheet - Management of Drug Company Contact and Financial Account Information 1. Unique 4 or 5 digit Company Code Every drug company that Health Canada interacts with in the areas of Drug Submissions, Drug Right to Sell, and Drug Establishment Licencing is assigned its…

Guidance Document - Fees for the right to sell drugs Date adopted: 1997/05/01 Date posted: 2025/06/10 Effective date: 2025/05/31 PDF format (432 Kb, 15 pages) Access archived version of this document Document change log Version Guidance Document: Fees for the Right to Sell Drugs…

Fees for the right to sell drugs for human use Fees for the right to sell drugs for human use as of April 1, 2026 Item Description Fee as of April 1, 2025 Fee as of April 1, 2026 Drugs (DINs) The annual fee for the right to sell a drug (disinfectant, non-prescription drug, or a…